Reading time ( words)
Today, Jabil Inc. has reported preliminary, unaudited financial results for its second quarter of fiscal year 2019.
“I’m extremely pleased with our outstanding second quarter results, which further demonstrate the success of our diversification strategy,” said CEO Mark Mondello. “Quite simply, our approach is working, both in terms of our strategy and operational excellence. This is well-illustrated by our performance in the first half of the fiscal year,” he added.
Second Quarter of Fiscal Year 2019 Highlights:
- Net revenue: $6.1 billion
- Diversified Manufacturing Services (DMS) year-on-year revenue decrease: 7%
- Electronics Manufacturing Services (EMS) year-on-year revenue growth: 33%
- U.S. GAAP operating income: $154.0 million
- U.S. GAAP diluted earnings per share: $0.43
- Core operating income (Non-GAAP): $191.1 million
- Core diluted earnings per share (Non-GAAP): $0.64
Healthcare Business Update:
During the second fiscal quarter, Jabil successfully transitioned the first two sites from Johnson & Johnson Medical Devices Companies (JJMDC) as part of the previously announced strategic collaboration between the companies.
“I’m honored to welcome our new employees from these outstanding healthcare facilities,” said Mondello. “Our new team members bring forward terrific experience, elevating and expanding Jabil’s capabilities in our healthcare business,” he added.
General Business Update:
“As we move into the back half of our fiscal year, our outlook for revenue and core EPS remain strong, supported by strength in our healthcare, retail, cloud and industrial businesses,” said Mondello.
Jabil is a product solutions company providing comprehensive design, manufacturing, supply chain and product management services. Operating from over 100 facilities in 29 countries, Jabil delivers innovative, integrated and tailored solutions to customers across a broad range of industries. For more information, visit jabil.com.